HIV drug resistance early warning indicators in Ethiopia: Variability at regional and health facility levels and trend over time.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 21 08 2019
revised: 14 02 2020
accepted: 14 02 2020
pubmed: 24 2 2020
medline: 21 8 2020
entrez: 24 2 2020
Statut: ppublish

Résumé

The aim of this study was to assess status of early warning indicators (EWIs) for HIV drug resistance in Ethiopia. A retrospective cohort study was conducted among 90 health facilities (HFs) in 2015. Data were abstracted for 'on time pill pickup' (EWI-I), 'Retention in care' (EWI-II), 'drug supply continuity'(EWI-III) and 'dispensing practices' (EWI-IV). Data analysis was conducted using WHO Excel tool and SPSS V20. EWI-IV was excellent across all of the six rounds of EWI surveys conducted between 2008 and 2015. There were improvements in EWI-II over time from 55.6% to 81%. However, EWI-I and EWI-III declined from 86.7% to 31% and 100% to 41%, respectively. During 2015, half of the HFs in Gambella, Amhara and Southern Nation, Nationalities and people regional (SNNPR) states achieved excellent performance for EWI-I. Similarly, all HFs in Afar, Amhara, Dire Dawa, Harari and Tigray regions achieved excellent performance for EWI-II. There were also differences by level of HFs for EWI-III; 62% of hospitals and 28% of health centers were out of stock of one or more ARV drugs by 2015. Excellent performance of EWI-IV and improvement of EWI-II over time shall be maintained. The program shall further work to ensure medication adherence and supply continuity.

Identifiants

pubmed: 32088338
pii: S1201-9712(20)30089-8
doi: 10.1016/j.ijid.2020.02.031
pii:
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-97

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Yimam Getaneh (Y)

Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia. Electronic address: yimamgetaneh@gmail.com.

Kidist Zealyas (K)

Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia.

Fekadu Adugna (F)

World Health Organization, Country office, Addis Ababa, Ethiopia.

Kussito Kursha (K)

Center for Disease Prevention and Control, Country office, Addis Ababa, Ethiopia.
Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia.

Desta Kassa (D)

Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, P.O. Box 1242, Addis Ababa, Ethiopia.

Yibeltal Assefa (Y)

School of Public health, the University of Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH